Even with revolutionary advances in biomedical innovation, the therapeutic gains of life-saving medications are all too often out of reach for millions of Americans. The sky-high prices and complex financing arrangements make the utilization of life-saving medicines all but unaffordable.
Read MoreThe diabetic population in the United States has rapidly grown in recent decades, with the percentage of Americans with diabetes jumping from 0.98% in 1958 to 7.40% in 2015, causing an ever-increasing need for accessible insulin. However, as rates of diabetes have risen, so too has the cost of insulin, restricting the access of many patients to the medication necessary for their survival. Unsurprisingly, the number of people succumbing to diabetes has also risen in recent years due to the high prices of their treatments, including insulin.
Read More
